Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

138.21

+2.13 (1.57%)

At close: Jun 10, 2025, 4:00 PM

138.99

+0.78 (0.56%)

After-hours: Jun 10, 2025, 6:34 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Genetic Medicines	290.52M	Log In
Genetic Medicines Growth	473.02%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	290.52M	Log In
United States Growth	473.02%	Log In